NHC Comments on FDA – Pharmacy Compounding Advisory Committee Meeting on Bulk Drug Substances for Section 503A 07/22/2026 Read More
NHC’s Comments on the CMS Proposed Rule on Interoperability and Prior Authorization 06/16/2026 Read More
NHC Comments on Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure 04/15/2026 Read More
